-
Intelligent Drug Discovery Market Size, Growth, Sales Revenue, Opportunity, and Industry Expansion Strategies to 2027
21 Oct 2021 11:53 GMT
… pharmaceutical companies are focusing on the development of drugs using artificial intelligence. The pharma … Global Intelligent Drug Discovery Market … Research Organizations
Pharmaceutical & … prevalence of respiratory diseases
4.2 …
-
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv Budesonide Nasal Spray
21 Oct 2021 09:40 GMT
… ® is the first medication originating from Marinomed… is the first drug developed on the Marinosolv® … to provide better treatment options for patients … Pharmaceutical said, "We are looking forward to the cooperation with Marinomed. Respiratory disease …
-
Here's who prescribed ivermectin to treat severely ill COVID-19 patients in NY hospitals
21 Oct 2021 09:16 GMT
… an anti-parasitic drug, ivermectin, to treat severely ill … ineffective as a treatment for the respiratory disease. Zelenko did … and other drugs, if they get the respiratory disease, court records … medication for decades and some promising results in treating …
-
Respiratory Diagnostics Market SWOT Analysis by Size, Status, Development and Forecast 2021-2030
21 Oct 2021 05:46 GMT
… advancements in the development of novel drugs, coupled with … and the need for treatment that can lower … the major respiratory diseases. Due to prevalence in respiratory diseases, respiratory … focus include healthcare & pharmaceuticals, ICT & Telecom, …
-
Synairgen treatment for Covid given safety nod for phase-three trial
20 Oct 2021 06:52 GMT
… Respiratory diseases focused Synairgen said a safety oversight board had recommended a trial … and final phase.
Synairgen is developing SNG001, a formulation for inhalation … protein interferon beta, for the treatment of severe viral lung infections …
-
The FDA authorizes Moderna and J&J COVID vaccine boosters
20 Oct 2021 21:27 GMT
… Images
The Food and Drug Administration authorized booster doses … vaccinated," said Acting FDA Commissioner Janet Woodcock in … for Immunizations and Respiratory Diseases, during the FDA meeting Friday. The … authorization matches the one FDA gave to Pfizer- …
-
Water-Soluble Drugs Market Segmentation, Industry Analysis By Production, Consumption, Revenue And Growth Rate By 2027
20 Oct 2021 12:33 GMT
… on the pharmacokinetics & pharmacodynamics of the drug.
VANCOUVER, … the latest technological developments, R&D … -Soluble Drugs Market Segmentation
Drug Type
Paracetamol … Increasing prevalence of respiratory diseases
4.2.2 …
-
Mobile C-Arms Market Top Countries Data, Company Overview, Regional Economy, Development and Forecast to 2027
20 Oct 2021 13:05 GMT
… the latest trends, growth factors, developments, opportunities, and competitive landscape. … 4.2.2. Nanopharmaceutical Drugs Market drivers analysis
4.2 … 2.3. Increasing prevalence of respiratory diseases
4.2.2.4. …
-
Molecular Forensics Market Size, Business Opportunities By Leading Players, Share, Development & Research Report
20 Oct 2021 12:33 GMT
… Continuous investment in research and development and favorable regulations will propel … 4.2.2. Nanopharmaceutical Drugs Market drivers analysis
4.2 … 2.3. Increasing prevalence of respiratory diseases
4.2.2.4. …
-
Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis
19 Oct 2021 09:53 GMT
… exclusive global rights to develop, manufacture, register, … therapy for the treatment of cystic fibrosis. … development partnership among academia, life science investors, pharma, … discovery and development of therapies in respiratory diseases combined …
About
© 1995-2021